Logo image of TALEA.MI

TALEA GROUP SPA (TALEA.MI) Stock Fundamental Analysis

BIT:TALEA - Euronext Milan - IT0005378333 - Common Stock - Currency: EUR

5.28  -0.1 (-1.86%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TALEA. TALEA was compared to 23 industry peers in the Consumer Staples Distribution & Retail industry. TALEA may be in some trouble as it scores bad on both profitability and health. TALEA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TALEA has reported negative net income.
In the past year TALEA had a positive cash flow from operations.
TALEA had negative earnings in each of the past 5 years.
In multiple years TALEA reported negative operating cash flow during the last 5 years.
TALEA.MI Yearly Net Income VS EBIT VS OCF VS FCFTALEA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

TALEA has a Return On Assets of -6.06%. This is amonst the worse of the industry: TALEA underperforms 82.61% of its industry peers.
Looking at the Return On Equity, with a value of -29.09%, TALEA is doing worse than 86.96% of the companies in the same industry.
Industry RankSector Rank
ROA -6.06%
ROE -29.09%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TALEA.MI Yearly ROA, ROE, ROICTALEA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -50

1.3 Margins

With an excellent Gross Margin value of 28.25%, TALEA belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
In the last couple of years the Gross Margin of TALEA has declined.
TALEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.82%
GM growth 5Y-3.93%
TALEA.MI Yearly Profit, Operating, Gross MarginsTALEA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

TALEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for TALEA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TALEA.MI Yearly Shares OutstandingTALEA.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
TALEA.MI Yearly Total Debt VS Total AssetsTALEA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that TALEA is in the distress zone and has some risk of bankruptcy.
TALEA has a Altman-Z score of 1.04. This is amonst the worse of the industry: TALEA underperforms 86.96% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that TALEA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.73, TALEA is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACCN/A
WACC6.1%
TALEA.MI Yearly LT Debt VS Equity VS FCFTALEA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

2.3 Liquidity

TALEA has a Current Ratio of 0.64. This is a bad value and indicates that TALEA is not financially healthy enough and could expect problems in meeting its short term obligations.
TALEA's Current ratio of 0.64 is on the low side compared to the rest of the industry. TALEA is outperformed by 82.61% of its industry peers.
TALEA has a Quick Ratio of 0.64. This is a bad value and indicates that TALEA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.27, TALEA is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.27
TALEA.MI Yearly Current Assets VS Current LiabilitesTALEA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.07% over the past year.
The Revenue has decreased by -3.10% in the past year.
TALEA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.78% yearly.
EPS 1Y (TTM)58.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.2%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y15.59%
Revenue growth 5Y27.78%
Sales Q2Q%-17.38%

3.2 Future

The Earnings Per Share is expected to grow by 126.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.65% on average over the next years. This is quite good.
EPS Next Y263.31%
EPS Next 2Y126.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.99%
Revenue Next 2Y14.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TALEA.MI Yearly Revenue VS EstimatesTALEA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
TALEA.MI Yearly EPS VS EstimatesTALEA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

TALEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 12.66 indicates a correct valuation of TALEA.
The rest of the industry has a similar Price/Forward Earnings ratio as TALEA.
TALEA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.71.
Industry RankSector Rank
PE N/A
Fwd PE 12.66
TALEA.MI Price Earnings VS Forward Price EarningsTALEA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TALEA.MI Per share dataTALEA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

TALEA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TALEA's earnings are expected to grow with 126.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y126.56%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TALEA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALEA GROUP SPA

BIT:TALEA (7/22/2025, 7:00:00 PM)

5.28

-0.1 (-1.86%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.44%
Inst Owner ChangeN/A
Ins Owners48.13%
Ins Owner ChangeN/A
Market Cap44.88M
Analysts86.67
Price Target10.2 (93.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.66
P/S 0.33
P/FCF N/A
P/OCF 5.15
P/B 1.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)0.42
Fwd EY7.9%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)1.02
OCFY19.4%
SpS16.19
BVpS3.43
TBVpS-4.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -29.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.82%
GM growth 5Y-3.93%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 202.09%
Cap/Sales 6.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.27
Altman-Z 1.04
F-Score4
WACC6.1%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.2%
EPS Next Y263.31%
EPS Next 2Y126.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y15.59%
Revenue growth 5Y27.78%
Sales Q2Q%-17.38%
Revenue Next Year19.99%
Revenue Next 2Y14.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-683.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y242.23%
OCF growth 3YN/A
OCF growth 5YN/A